Australia opens consultation on cannabis cultivation rules ahead of 2027 sunset

Regulators seek input on domestic growing standards as medicinal cannabis framework nears expiration.

FILE — statehouse · B.D. Gilfry / CC BY-SA 2.0

Australia has launched a public consultation on cultivation rules for its medicinal cannabis program, according to MMJDaily. The move comes as the country's current regulatory framework faces a 2027 sunset, requiring policymakers to decide whether and how to extend the regime governing domestic production.

The consultation suggests authorities are weighing operational details—likely including licensing, quality standards, and supply-chain oversight—before the deadline. Recent activity by major producers including Tilray, Aurora, and Avicanna's SMGH subsidiary indicates commercial momentum in the Australian market, with companies expanding product lines and completing exports as of early 2026.

Key question ahead: whether the final rules will sustain or restrict the competitive structure now emerging. Australia's earlier establishment of a THC driving limit for medicinal users signals intent to build a functioning medical framework; how cultivation rules are written could determine whether domestic producers can compete with imports and meet patient demand.